Articles From: Lifetime Brands, Inc. Reports Second Quarter Financial Results to Ligand Licenses Captisol-enabled™ Lamotrigine to CURx Pharmaceuticals, Inc.


2014/8/5
Lifetime Brands, Inc. (NasdaqGS:LCUT), a leading global provider of branded kitchenware, tableware and other products used in the home, today reported its financial results for the second quarter ended June 30, 2014.
Sign-up for Lifetime Brands, Inc. Reports Second Quarter Financial Results investment picks
2014/7/18
ADVISORY, July 18, 2014 (GLOBE NEWSWIRE) -- What: Lifetime's Project Runway All Stars will visit the NASDAQ Marketsite in Times Square.
Sign-up for Lifetime(R)'s Project Runway All Stars(TM) to Ring The NASDAQ Stock Market Closing Bell investment picks
SALT LAKE CITY, June 16, 2014 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) , a company dedicated to helping people achieve healthy living through a combination of a compelling business opportunity and scientifically validated products, today announced that it has appointed Jeffery Bean as its new Managing Director in Japan.
Sign-up for LifeVantage Announces Changes in Its Japan Operations investment picks
Fourth Quarter Revenue Increased to Record $56M SALT LAKE CITY, Sept.
Sign-up for LifeVantage Announces Fourth Quarter and Full Fiscal Year 2014 Results investment picks
Fourth Quarter Net Revenue Increased 8.8% Over Prior Year Period to $56M SALT LAKE CITY, Aug.
Sign-up for LifeVantage Announces Preliminary Fourth Quarter and Full Fiscal 2014 Results investment picks
SALT LAKE CITY, Sept.
Sign-up for LifeVantage to Present at the Imperial Capital Global Opportunities Conference investment picks
Second Quarter Net Sales Increase 28% to $29.6 Million MORTON GROVE, Ill.
Sign-up for Lifeway Foods Announces Results for the Second Quarter of 2014 investment picks
Lifeway Foods Brings Kefir to Canada, Debuting in 1,000+ Stores Nationwide Second International Expansion in 14 Months for Leading Probiotic Beverage Manufacturer Canada NewsWire MORTON GROVE, Ill.
Sign-up for Lifeway Foods Brings Kefir to Canada, Debuting in 1,000+ Stores Nationwide investment picks
Second International Expansion in 14 Months for Leading Probiotic Beverage Manufacturer MORTON GROVE, Ill.
Sign-up for Lifeway Foods Brings Kefir to Canada, Debuting in 1,000+ Stores Nationwide investment picks
Leading Kefir Supplier to Train and Mentor Interns to Improve Professional Opportunities MORTON GROVE, Ill.
Sign-up for Lifeway Foods Makes Clinton Global Initiative America Commitment to Action To Create Internship Program for Underserved Youth investment picks
MORTON GROVE, Ill.
Sign-up for Lifeway Foods, Inc. to Announce Results for the Second Quarter Ended June 30, 2014 investment picks
Intercontinental Exchange (NYSE: ICE), the leading global network of exchanges and clearing houses, announced today that daily volume records were reached in Liffe Long Gilt futures and Ultra Long Gilt futures with 1,042,074 contracts and 5,118 contracts traded respectively on August 26, 2014.
Sign-up for Liffe Sets Daily Volume Record in Long Gilt and Ultra Long Gilt Futures, Long Gilt Futures Surpass 1,000,000 Daily Contract Mark investment picks
NEW YORK , June 14, 2014 /PRNewswire/ -- Annie's, Inc. Lifshitz & Miller announces that a class action was filed in the United States District Court for the Northern District of California alleging Annie's, Inc. (BNNY) and certain of its officers and directors issued false and misleading statements between August 8, 2013 and June 3 , 2014.
Sign-up for Lifshitz & Miller Law Firm Announces Investigation of Annie's, Inc., Montage Technology Group Limited, OpenTable, Inc., Provectus Biopharmaceuticals, Inc., and The Bancorp Inc. investment picks
2014/7/4
NEW YORK , July 4, 2014 /PRNewswire/ -- Auxilium Pharmaceuticals Inc. Lifshitz & Miller announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of Auxilium Pharmaceuticals Inc. ("AUXL") to Owens & Minor, Inc. in an all-stock deal valued at approximately $851 million .
Sign-up for Lifshitz & Miller Law Firm Announces Investigation of Auxilium Pharmaceuticals Inc., First Citizens Bancorporation, Medical Action Industries Inc., Regado Biosciences, Inc., Sport Chalet Inc., and Vitacost.com, Inc. investment picks
2014/9/2
NEW YORK , Sept 2, 2014 /PRNewswire/ -- China Housing & Land Development, Inc. ("CHLN") Lifshitz & Miller announces an investigation into possible breaches of fiduciary duties in connection with the proposed going private transaction of CHLN (the "Transaction"). The Transaction includes a reverse stock split, whereby every 50,000 shares of CHLN's common stock will be converted into one share of common stock.
Sign-up for Lifshitz & Miller Law Firm Announces Investigation of China Housing & Land Development, Inc., Cobra Electronics Corporation, Compuware Corporation, InterMune, Inc., International Rectifier Corporation, Peregrine Semiconductor Corporation and XRS Corporation investment picks
2014/6/18
NEW YORK , June 18, 2014 /PRNewswire/ -- Covisint Corporation Lifshitz & Miller announces that a class action was filed in the United States District Court for the Southern District of New York alleging that Covisint Corporation ("COVS") issued false and misleading statements.
Sign-up for Lifshitz & Miller Law Firm Announces Investigation of Covisint Corporation, Fusion-io, Inc., Infoblox, Inc., Ocean Power Technologies, Inc., and tw telecom inc. investment picks
2014/7/31
NEW YORK , July 31, 2014 /PRNewswire/ -- Design Within Reach, Inc. Lifshitz & Miller announces an investigation into possible breaches of fiduciary duties in connection with the proposed sale of Design Within Reach, Inc. ("DWRI") to Herman Miller , Inc. in a transaction valued at approximately $23.00 per share.
Sign-up for Lifshitz & Miller Law Firm Announces Investigation of Design Within Reach, Inc., Family Dollar Stores, Inc., GFI Group Inc., Intermountain Community Bancorp, Rockwood Holdings, Inc., and Salix Pharmaceuticals Ltd. investment picks
2014/6/25
NEW YORK , June 25, 2014 /PRNewswire-USNewswire/ -- Endocyte, Inc. Lifshitz & Miller announces that a class action was filed in the United States District Court for the Southern District of Indiana alleging that Endocyte, Inc. ("ECYT") issued false and misleading statements between March 21, 2014 and May 2 , 2014.
Sign-up for Lifshitz & Miller Law Firm Announces Investigation of Endocyte, Inc., Integrys Energy Group, Inc., MICROS Systems, Inc., Measurement Specialties, Inc., and PLX Technology, Inc. investment picks
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that data from a Phase 1 study of the selective estrogen receptor modulator (SERM) lasofoxifene were featured in a poster presentation today at ICE/ENDO 2014 in Chicago.
Sign-up for Ligand Announces Presentation of Positive Data from a Phase 1 Study on the Effect of the SERM Lasofoxifene to Increase Testosterone Levels in Men investment picks
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today that it intends to offer, subject to market conditions and other factors, $225 million aggregate principal amount of convertible senior notes due 2019 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”) and that its Board of Directors has authorized a $200 million share repurchase program over the next 12 months.
Sign-up for Ligand Announces Proposed Offering of $225 Million of Convertible Senior Notes and Announces $200 Million Share Repurchase Program investment picks
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced data from a Phase 1 clinical trial with LGD-6972 that demonstrate favorable safety, tolerability and pharmacokinetics in normal healthy volunteers and in subjects with type 2 diabetes mellitus, and also demonstrate a robust response on fasting plasma glucose after a single dose.
Sign-up for Ligand Announces Successful First-in-Human Trial Results for Glucagon Program investment picks
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) announced today that Chairman John W.
Sign-up for Ligand Chairman Dr. John W. Kozarich Named Director of the Year Honoree by Corporate Directors Forum investment picks
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced it has expanded its global license agreement with CURx Pharmaceuticals, Inc. to also include the development and commercialization of Ligand’s Captisol-enabled™ Lamotrigine program.
Sign-up for Ligand Licenses Captisol-enabled™ Lamotrigine to CURx Pharmaceuticals, Inc. investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Lifetime Brands, Inc. Reports Second Quarter Financial Results to Ligand Licenses Captisol-enabled™ Lamotrigine to CURx Pharmaceuticals, Inc.
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices